An update on current pharmacotherapeutic options for the treatment of ulcerative colitis
F Ferretti, R Cannatelli, MC Monico, G Maconi… - Journal of Clinical …, 2022 - mdpi.com
The main goals of Ulcerative Colitis (UC) treatment are to both induce and maintain the
clinical and endoscopic remission of disease, reduce the incidence of complications such as …
clinical and endoscopic remission of disease, reduce the incidence of complications such as …
New therapeutics for ulcerative colitis
RP Hirten, BE Sands - Annual review of medicine, 2021 - annualreviews.org
Ulcerative colitis (UC) is a relapsing and remitting inflammatory disease of the colon with a
variable course. Despite advances in treatment, only approximately 40% of patients achieve …
variable course. Despite advances in treatment, only approximately 40% of patients achieve …
Emerging therapies for ulcerative colitis: updates from recent clinical trials
T AlAmeel, A AlMutairdi… - Clinical and Experimental …, 2023 - Taylor & Francis
Ulcerative colitis (UC) is a chronic and progressive inflammatory disorder that affects the
colon. The advent of advanced therapies such as biologic agents and small molecules has …
colon. The advent of advanced therapies such as biologic agents and small molecules has …
Emerging therapies for ulcerative colitis
J Hanzel, MS Hulshoff, J Grootjans… - Expert Review of …, 2022 - Taylor & Francis
Introduction Despite advances in the medical management of ulcerative colitis (UC), a
subgroup of patients does not respond to currently available therapies. A number of novel …
subgroup of patients does not respond to currently available therapies. A number of novel …
Ulcerative colitis: current and emerging treatment strategies
Historically, medical therapy for ulcerative colitis (UC) was limited to corticosteroids.
Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded …
Excitingly, over the past just 1–2 decades, the options for medical therapy have expanded …
Breaking the therapeutic ceiling in drug development in ulcerative colitis
D Alsoud, B Verstockt, C Fiocchi… - The lancet …, 2021 - thelancet.com
Increased knowledge of the intricate pathogenesis of ulcerative colitis has triggered an
advance in drug development during the past two decades, resulting in the advent of several …
advance in drug development during the past two decades, resulting in the advent of several …
Treatment algorithm for mild and moderate-to-severe ulcerative colitis: an update
E Burri, MH Maillard, AM Schoepfer, F Seibold… - Digestion, 2020 - karger.com
Background: Patient care in ulcerative colitis (UC) remains challenging despite an array of
established treatment options and emerging new therapies. The management of UC therapy …
established treatment options and emerging new therapies. The management of UC therapy …
Therapeutic strategies for the management of ulcerative colitis
Induction and maintenance of remission, mucosal healing, the avoidance of surgical
intervention, and decreasing the likelihood of cancer developing are the primary therapeutic …
intervention, and decreasing the likelihood of cancer developing are the primary therapeutic …
Small molecule oral targeted therapies in ulcerative colitis
UN Shivaji, OM Nardone, R Cannatelli… - The Lancet …, 2020 - thelancet.com
The incidence and prevalence of ulcerative colitis are increasing globally. Although the
exact cause and pathogenesis of this disease is unclear, research has led to a better …
exact cause and pathogenesis of this disease is unclear, research has led to a better …
New therapeutic avenues in ulcerative colitis: thinking out of the box
J Torres, S Danese, JF Colombel - Gut, 2013 - gut.bmj.com
Ulcerative colitis (UC) is a chronic idiopathic inflammatory disease of the gastrointestinal
tract that affects the mucosal lining of the colon. Recent epidemiological data show that its …
tract that affects the mucosal lining of the colon. Recent epidemiological data show that its …